Template:SubstanceBox/Gabapentin: Difference between revisions

>Isaak
Common names correctly annotated.
>Isaak
Annotate bioavailability correctly
 
(2 intermediate revisions by 2 users not shown)
Line 54: Line 54:
     |OralROA_Collapsed=false
     |OralROA_Collapsed=false
     |OralROA_Caption=
     |OralROA_Caption=
     |OralROA_Bioavailability=27% - 60%<ref>"Gabapentin dosing, indications, interactions, adverse effects, and more". | http://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011#showall</ref>
     |OralROA_Bioavailability=[[Oral min bioavailability::27]]% - [[Oral max bioavailability::60]]%<ref name="NeurotoninMedScape">{{Citation | title=Neurontin, Gralise (gabapentin) dosing, indications, interactions, adverse effects, and more | url=https://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011}}</ref>
     |OralROA_Threshold=[[Oral threshold dose::200]] [[Oral dose units::mg]]
     |OralROA_Threshold=[[Oral threshold dose::200]] [[Oral dose units::mg]]
     |OralROA_Light=[[Oral min light dose::200]] - [[Oral max light dose::900]] mg
     |OralROA_Light=[[Oral min light dose::200]] - [[Oral max light dose::900]] mg
Line 64: Line 64:
     |OralROA_Duration=[[Oral min total time::6]] - [[Oral max total time::10]] [[Oral total time units::hours]]
     |OralROA_Duration=[[Oral min total time::6]] - [[Oral max total time::10]] [[Oral total time units::hours]]
     |OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time::120]] [[Oral onset time units::minutes]]
     |OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time::120]] [[Oral onset time units::minutes]]
     |OralROA_Peak=[[Oral min peak time::120]] - [[Oral max peak time::180]] [[Oral onset time units::minutes]]
     |OralROA_Peak=[[Oral min peak time::120]] - [[Oral max peak time::180]] [[Oral peak time units::minutes]]
     |OralROA_Offset=
     |OralROA_Offset=
     |OralROA_Aftereffects=
     |OralROA_Aftereffects=


}}
}}